These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19168847)

  • 1. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis.
    Cassidy FH; Yokoo T; Aganovic L; Hanna RF; Bydder M; Middleton MS; Hamilton G; Chavez AD; Schwimmer JB; Sirlin CB
    Radiographics; 2009; 29(1):231-60. PubMed ID: 19168847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination.
    Bashir MR; Merkle EM; Smith AD; Boll DT
    Eur J Radiol; 2012 Feb; 81(2):e101-9. PubMed ID: 21330083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of liver fat with magnetic resonance imaging.
    Reeder SB; Sirlin CB
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):337-57, ix. PubMed ID: 21094444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique.
    Boll DT; Marin D; Redmon GM; Zink SI; Merkle EM
    AJR Am J Roentgenol; 2010 Apr; 194(4):964-71. PubMed ID: 20308498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR fat fraction mapping: a simple biomarker for liver steatosis quantification in nonalcoholic fatty liver disease patients.
    Leitão HS; Paulino C; Rodrigues D; Gonçalves SI; Marques C; Carvalheiro M; Geraldes CF; Caseiro-Alves F
    Acad Radiol; 2013 Aug; 20(8):957-61. PubMed ID: 23830602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging-based quantification of hepatic fat: methods and clinical applications.
    Ma X; Holalkere NS; Kambadakone R A; Mino-Kenudson M; Hahn PF; Sahani DV
    Radiographics; 2009; 29(5):1253-77. PubMed ID: 19755595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2*-corrected chemical shift MRI.
    Joe E; Lee JM; Kim KW; Lee KB; Kim SJ; Baek JH; Shin CI; Suh KS; Yi NJ; Han JK; Choi BI
    J Magn Reson Imaging; 2012 Nov; 36(5):1124-30. PubMed ID: 22761083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.
    Guaraldi G; Besutti G; Stentarelli C; Zona S; Nocetti L; Loria P; Ballestri S; Losi L; Torricelli P; Ligabue G
    Antivir Ther; 2012; 17(6):965-71. PubMed ID: 22766513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating childhood obesity: magnetic resonance-based quantification of abdominal adipose tissue and liver fat in children.
    Raschpichler MC; Sorge I; Hirsch W; Mende M; Sergeyev E; Kruber D; Koerner A; Schick F
    Rofo; 2012 Apr; 184(4):324-32. PubMed ID: 22322443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods.
    Gloor M; Fasler S; Fischmann A; Haas T; Bieri O; Heinimann K; Wetzel SG; Scheffler K; Fischer D
    J Magn Reson Imaging; 2011 Jan; 33(1):203-10. PubMed ID: 21182140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
    Schuchmann S; Weigel C; Albrecht L; Kirsch M; Lemke A; Lorenz G; Warzok R; Hosten N
    Eur J Radiol; 2007 Jun; 62(3):416-22. PubMed ID: 17267159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging.
    Borra RJ; Salo S; Dean K; Lautamäki R; Nuutila P; Komu M; Parkkola R
    Radiology; 2009 Jan; 250(1):130-6. PubMed ID: 19017926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation.
    Maruzzelli L; Parr AJ; Miraglia R; Tuzzolino F; Luca A
    Acad Radiol; 2014 Apr; 21(4):507-13. PubMed ID: 24594420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between multi-echo T2* with and without fat saturation pulse for quantification of liver iron overload.
    Sanches-Rocha L; Serpa B; Figueiredo E; Hamerschlak N; Baroni R
    Magn Reson Imaging; 2013 Dec; 31(10):1704-8. PubMed ID: 23978552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
    Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
    Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
    Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
    Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fat and iron at in-phase and opposed-phase MR imaging.
    Alústiza JM; Castiella A
    Radiology; 2008 Feb; 246(2):641. PubMed ID: 18227554
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.